Underediting of glutamate receptor GluR-B mRNA in malignant gliomas

In mammals, RNA editing by site-selective adenosine deamination regulates key functional properties of neurotransmitter receptors in the central nervous system. Glutamate receptor subunit B is nearly 100% edited at one position (the Q/R-site), which is essential for normal receptor function. Its significance is apparent from mouse models in which a slightly reduced rate of Q/R-site editing is associated with early onset epilepsy and premature death. Here we report that in tissues from malignant human brain tumors, this editing position of glutamate receptor subunit B is substantially underedited compared with control tissues. We also observe alterations in editing and alternative splicing of serotonin receptor 5-HT2C transcripts. These changes correlate with a decrease in enzymatic activity of the editing enzyme adenosine deaminase acting on RNA (ADAR) 2, as deduced from analysis of ADAR2 self-editing. Our results suggest a role for RNA editing in tumor progression and may provide a molecular model explaining the occurrence of epileptic seizures in association with malignant gliomas.

[1]  J. Haueisen,et al.  Source Localization and Possible Causes of Interictal Epileptic Activity in Tumor-Associated Epilepsy , 2000, Neurobiology of Disease.

[2]  A. Rich,et al.  Changing genetic information through RNA editing , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[3]  P. Seeburg,et al.  RNA editing in brain controls a determinant of ion flow in glutamate-gated channels , 1991, Cell.

[4]  P. Seeburg,et al.  Structural Requirements for RNA Editing in Glutamate Receptor Pre-mRNAs by Recombinant Double-stranded RNA Adenosine Deaminase (*) , 1996, The Journal of Biological Chemistry.

[5]  Henri Grosjean,et al.  Modification And Editing Of Rna , 1998 .

[6]  Christian Steinhäuser,et al.  News on glutamate receptors in glial cells , 1996, Trends in Neurosciences.

[7]  P. Seeburg,et al.  RNA editing of brain glutamate receptor channels: mechanism and physiology 1 Published on the World Wide Web on 5 February 1998. 1 , 1998, Brain Research Reviews.

[8]  W. Keller,et al.  Purification and properties of double-stranded RNA-specific adenosine deaminase from calf thymus. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[9]  V. Gallo,et al.  Glutamate regulates intracellular calcium and gene expression in oligodendrocyte progenitors through the activation of DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  David Julius,et al.  Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors , 1995, Nature.

[11]  A. Araque,et al.  Tripartite synapses: glia, the unacknowledged partner , 1999, Trends in Neurosciences.

[12]  P. Haydon,et al.  Physiological astrocytic calcium levels stimulate glutamate release to modulate adjacent neurons. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[13]  C. Ross,et al.  RNA Editing of the Glutamate Receptor Subunits GluR2 and GluR6 in Human Brain Tissue , 1994, Journal of neurochemistry.

[14]  T Kuner,et al.  Control of kinetic properties of AMPA receptor channels by nuclear RNA editing. , 1994, Science.

[15]  L. Chang,et al.  The human serotonin 5-HT2C receptor: complete cDNA, genomic structure, and alternatively spliced variant. , 1996, Genomics.

[16]  M. Nedergaard,et al.  ATP-Mediated Glia Signaling , 2000, The Journal of Neuroscience.

[17]  M. Herlyn,et al.  Mechanism for elimination of a tumor suppressor: aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  T. Dawson,et al.  Regulation of alternative splicing by RNA editing , 1999, Nature.

[19]  P. Seeburg,et al.  A mammalian RNA editing enzyme , 1996, Nature.

[20]  E. Fearon.  Human cancer syndromes: clues to the origin and nature of cancer. , 1997, Science.

[21]  W. Keller,et al.  RNA editing by base deamination: more enzymes, more targets, new mysteries. , 2001, Trends in biochemical sciences.

[22]  J. Loturco,et al.  Neural circuits in the 21st century: synaptic networks of neurons and glia. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Mayer,et al.  Glial cells of the oligodendrocyte lineage express both kainate- and AMPA-preferring subtypes of glutamate receptor , 1994, Neuron.

[24]  R. Emeson,et al.  Identification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing. , 1996, Molecular pharmacology.

[25]  Fang Liu,et al.  Glutamate-mediated astrocyte–neuron signalling , 1994, Nature.

[26]  I. R. Whittle,et al.  The Pathogenesis of Tumour Associated Epilepsy , 2000, Acta Neurochirurgica.

[27]  R. Emeson,et al.  Regulation of serotonin-2C receptor G-protein coupling by RNA editing , 1997, Nature.

[28]  Dirk Feldmeyer,et al.  Early-Onset Epilepsy and Postnatal Lethality Associated with an Editing-Deficient GluR-B Allele in Mice , 1995, Science.

[29]  A. Rich,et al.  Identification and characterization of a human tRNA-specific adenosine deaminase related to the ADAR family of pre-mRNA editing enzymes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[30]  K. Nishikura,et al.  Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Louis,et al.  A tiger behind many doors: multiple genetic pathways to malignant glioma. , 1995, Trends in genetics : TIG.

[32]  T. Sixma,et al.  A glia-derived acetylcholine-binding protein that modulates synaptic transmission , 2001, Nature.

[33]  Dennis D. Spencer,et al.  Hyperexcitability associated with localizable lesions in epileptic patients , 1992, Brain Research.

[34]  P. Somogyi,et al.  Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus , 2000, Nature.

[35]  D. Feldmeyer,et al.  Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2 , 2000, Nature.

[36]  D. Choi.  Calcium: still center-stage in hypoxic-ischemic neuronal death , 1995, Trends in Neurosciences.

[37]  T. Mansfield,et al.  DCC expression is altered by multiple mechanisms in brain tumours. , 1995, Oncogene.

[38]  S. Finkbeiner,et al.  Glutamate induces calcium waves in cultured astrocytes: long-range glial signaling. , 1990, Science.

[39]  B. Bass,et al.  RNA editing and hypermutation by adenosine deamination. , 1997, Trends in biochemical sciences.

[40]  J. Villemure,et al.  Epilepsy in patients with central nervous system tumors , 1996, Current opinion in neurology.